Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
August 24, 2020 08:00 ET
|
Cancer Genetics, Inc.
Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions RUTHERFORD, NJ and MAPLE GROVE, MN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the...
Cancer Genetics Reports Second Quarter 2020 Financial Results
August 14, 2020 07:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced...
Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
June 24, 2020 17:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates
June 01, 2020 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., June 01, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced financial...
Cancer Genetics Issues Letter to Shareholders
February 20, 2020 09:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and immuno-oncology...
Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
November 20, 2019 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...
Cancer Genetics, Inc. Announces Strategic Transactions
October 24, 2019 16:15 ET
|
Cancer Genetics, Inc.
Note Payment Received from Interpace Diagnostics Group, Inc. Settlement Agreement with NovellusDx Restructured Note Agreement with Unsecured Lender M&A Advisory Agreement with H.C....
Cancer Genetics Announces 1-for-30 Reverse Stock Split
October 24, 2019 08:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it...